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Introduction
In 1968, the Japanese Society of Chemotherapy (JSC)
established an agar dilution method for MIC determina-
tions of aerobic bacteria [1]. In 1979, the JSC established
an agar dilution method for MIC determinations of anaer-
obic bacteria. Furthermore, a revision of the agar dilution
standard was made in 1980, and this served as the standard
method for MIC determinations for an extensive period of
time in Japan. In 1990, the committee established a stan-
dard microbroth dilution method for MIC determinations.
This method was modiﬁed in 1992 for fastidious aerobic
and anaerobic bacteria [2].
In the development of standards for antimicrobial sus-
ceptibility testing, there has been a movement to incorpo-
rate pharmacologic as well as clinical considerations with
respect to in vitro antimicrobial susceptibility interpreta-
tions. This trend reﬂects the need to respond to the emer-
gence and spread of resistant microorganisms as well as a
greater understanding of pharmacokinetics and pharmaco-
dynamics and how it relates to improved patient outcome.
The Clinical Laboratory Standards Institute (CLSI) and the
European Committee on Antimicrobial Susceptibility
(EUCAST) are among the professional organizations that
proactively revise antimicrobial susceptibility testing on a
regular basis. JSC has also been revising its standards. In
2007, the agar dilution method was revised. After the
exclusion of selected organisms from the CLSI agar dilu-
tion standard, this method was adopted by the JSC [3].
With respect to revising the standard method for
microbroth dilution antimicrobial susceptibility testing, a
committee chaired by Keizo Yamaguchi was formed in
January 2008. The subcommittee’s ﬁrst task was to criti-
cally examine the methods for the antimicrobial suscepti-
bility testing of Haemophilus inﬂuenzae. Although JSC and
CLSI microbroth dilution methods both use a Mueller–
Hinton base, the supplements differ. This difference had
raised concerns among some Japanese clinical microbiol-
ogy professionals that there were many issues with the
CLSI method with respect to reported difﬁculties in mea-
suring endpoints and the poor growth of some strains.
Our ﬁrst action was to send questionnaires to the
members of the JSC and the Japanese Society for Clinical
Microbiology to better understand the technical problems
experienced in clinical microbiology laboratories regarding
microbroth dilution testing of H. inﬂuenzae. From the
responses to the questionnaire, it was clear that a major
problem in routine testing was the poor growth of
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H. inﬂuenzae isolates when the CLSI standard using
Haemophilus Test Medium Broth (HTM) was employed.
Based on this overwhelming response, we set out to re-
examine the performance of H. inﬂuenzae microbroth dilu-
tion testing methods at participating clinical microbiology
laboratories located in different geographical areas of Japan.
Materials and methods
Phase I studies
During this phase, we undertook a bacteriological investi-
gation of differences between the CLSI HTM and the JSC
media for microbroth dilution susceptibility testing of
H. inﬂuenzae. Factors studied included lot differences as
well as other factors related to test performance.
Methodology
Dried microbroth dilution plates (Eiken Chemical) for
testing H. inﬂuenzae were prepared using three lots of
cation-adjusted Mueller–Hinton broth (CAMHB) to which
hematin, NAD and yeast extract were added according to
the CLSI, whereas the supplements in the JSC method were
lysed horse blood, yeast extract and NAD. The respective
lots were labeled A, B and C and used at seven cooperating
laboratories to test two QC organisms: H. inﬂuenzae ATCC
49247, which is b-lactamase negative and ampicillin
resistant (BLNAR), and H. inﬂuenzae ATCC 49766. Each
lot of media was tested 30 times by both the JSC and CLSI
methods at each facility, and the geometric mean was
determined for each respective lot.
Antimicrobial agents tested
The following 8 antimicrobial agents were tested using
twofold dilutions by both methods on all lots: ampicillin
(ABPC 0.06–128 lg/ml); amoxicillin/clavulanic acid
(ACV 0.06/0.03–64/32 lg/ml; trimethoprim-sulfamethox-
azole (T/S 0.004/0.07–8/152 lg/ml), azithromycin (AZM
0.06–64 lg/ml), cefdinir (CFDN 0.03–64 lg/ml) and
ciproﬂoxacin (CPFX 0.001–2 lg/ml).
Antimicrobial susceptibility test media
The supplements added to cation-adjusted Mueller–Hinton
broth in the JSC and CLSA methods are shown in Table 1.
Adjustment of inoculum density
A bacterial suspension matching the turbidity of a 0.5
McFarland standard was prepared in MHB or physiological
saline using isolates grown on chocolate agar plates under
5% CO2 at 35 ± 2C for 20–24 h. From the adjusted
suspension, 50 ll was added to 13 ml of the JSC- and
CLSI-speciﬁed broths. After thoroughly mixing to ensure
an even suspension, 100 ll were dispensed into the cor-
responding microdilution wells within 15 min. Trays were
incubated in ambient air for 20–24 h at 35 ± 2C prior to
endpoint readings.
Assessment of lot-to-lot variation in test performance
The antimicrobial agents tested to assess lot variation were
based on quality control standards established by the CLSI.
Meropenem and cefdinir were excluded from the antimi-
crobial panel for testing H. inﬂuenzae ATCC 49247. For
meropenem and cefdinir testing, H. inﬂuenzae ATCC
49766 was utilized.
Lot performance was considered satisfactory if no more
than 2 out of 30 consecutive results for each drug–refer-
ence strain combination were outside the acceptable limits
established by the CLSI. If this frequency was exceeded,
the lot was excluded from the study. Furthermore, data
from facilities where quality-control MICs exceeded the
acceptable range of results by more than 5% were excluded
from the comparison of CLSI and JSC methodologies,
although data generated for lot-to-lot variation were
included.
Statistical analysis
Statistical analysis was performed using Excel 2007. The
Student t test was used to analyze the data. p values of
\0.05 were considered statistically signiﬁcant.
Participating sites
Nagasaki University Hospital Clinical Laboratory, Saga
University Medical School Hospital, Kobe University
Medical School Hospital Clinical Laboratory, Tenri Hospital,
Table 1 Comparison of the media used in the CLSI and JSC methods
for the broth microdilution susceptibility testing of H. inﬂuenza
Supplements to cation-adjusted Mueller–Hinton broth
JSC CLSI
NAD 15 lg/ml NAD 15 lg/ml
Lysed horse blood 2–5% Hematin 15 lg/ml




a Added when sulfonamide and trimethoprim are tested
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Fujita Health University, Juntendo University Medical
School University Clinical Laboratory, and Sapporo
University Medical School Hospital Clinical Laboratory.
Phase II studies
This phase involved a comparative evaluation of the ability
of the JSC and CLSI test media to determine the MIC and
to support the growth of H. inﬂuenzae.
Analysis of factors affecting MIC determinations
The methodology employed was identical to that of phase
I. Eiken Chemical cation-adjusted Mueller–Hinton dried
microbroth dilution plates were supplemented with addi-
tives according to the JSC and CLSI. One lot was chosen
for testing among lots that was within acceptable CLSI
ranges when tested by reference quality-control strains.
For interlaboratory precision studies, the following iso-
lates were used: (a) 40 reference isolates (20 which grew
well on media and 20 which grew poorly on media; isolates
included BLNAR, b-lactamase non-producing, ampicillin-
susceptible (BLNAS), and b-lactamase-producing, ampi-
cillin-resistant (BLPAR) organisms); (b) 30 non-duplicate
isolates recovered at participating sites during the period
October to December 2008.
During phase II, the geometric mean MIC value for each
antimicrobial agent tested was determined for each par-
ticipating site. The geometric mean MIC values generated
by the CLSI and JSC methods during interlaboratory
studies using 40 reference organisms as well as consecu-
tively recovered isolates at each participating site were
compared with respect to statistically signiﬁcant differ-
ences. Similar to phase I of the project, if the quality-
control MIC for a particular drug/reference strain exceeded
the acceptable range of results by more than 5%, the
geometric mean MIC value for that particular drug was
excluded from the data.
Comparison of growth on the CLSI and JSC test method
media
Two approaches were used in growth comparisons. In the
interlaboratory comparative study using 40 reference
organisms, the growth comparison was based on the visual
assessment of a designated investigator at each facility. In
the second approach, the 40 reference organisms were
characterized as BLNAR, low BLNAR, BLNAS and
BLPAR based on the presence or absence of TEM type
b-lactamase and mutations within the ftsI gene. After 24
and 48 h of incubation, the turbidity (600 nm OD) was
compared atMitsubishi ChemicalMedience, Chemotherapy
Division.
Primers for detection of H. inﬂuenzae resistance genes
(Wakunaga Pharmaceutical Co, Osaka) were used
according to the manufacturer’s protocol. On the basis of
the PCR results, isolates demonstrating only a Lys-526
substitution in the ftsI gene were identiﬁed as low-BLNAR
consistent with low-level b-lactam resistance. Isolates
lacking all resistance genes were classiﬁed as BLNAS.
Statistics
Statistical analysis was performed using Excel 2007. The
student t test was used to analyze the data. p values of
\0.05 were considered statistically signiﬁcant.
Participating sites
Nagasaki University Hospital Clinical Laboratory, Kobe
University Hospital Clinical Laboratory, Tenri Hospital,
Fujita Health University, Juntendo University Medical
School University Clinical Laboratory, Sapporo University
Medical School Hospital Clinical Laboratory, and Mitsu-




Using the H. inﬂuenzae ATCC 49247 and ATCC 49266
strains, the performances of lots A, B, and C were evalu-
ated to determine whether MICs generated for the drugs
tested were within acceptable quality-control MIC ranges
for the reference strains. While the MICs for azithromycin
were somewhat lower when using the CLSI method rather
than the JSC method, the MICs generated by both methods
were comparable in all lots tested (Table 2).
Phase II studies
Factors affected MIC values
Interlaboratory MICs generated using 40 reference
strains Table 3 shows interlaboratory geometric mean
MICs generated for each participating facility using both
the JSC and the CLSI methods for all lots tested. With
respect to b-lactam antimicrobial agents, the geometric
mean MICs based on the JSC method were signiﬁcantly
higher than the CLSI method (p\ 0.05). This difference
was most pronounced with ABPC, where the ratio between
the JSC and CLSI method was 1.86 (p\ 0.0064). The
antimicrobial agent that gave the lowest JSC/CLSI method
ratio difference was CTRX, with 1.22 (p = 0.0123).
136 J Infect Chemother (2012) 18:134–143
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A similar trend was even observed for AZM, with the
MICs generated by the JSC method being higher than
those obtained with the CLSI method, as shown by a
JSC/CLSI method ratio of 1.60 (p = 0.0003). For CPFX,
the JSC/CLSI ratio was lower at 1.21, although there was
still a signiﬁcant difference (p = 0.0034). The one
exception was seen with T/S, where the CLSI geometric
mean MIC was higher (JSC/CLSI ratio of 0.64,
p = 0.0004).
MICs generated at each site for consecutive clinical iso-
lates The interlaboratory results in Table 4 show that,
although the differences are not as striking as those
observed with the 40 reference strains, higher MICs were
Table 2 Geometric mean MICs generated for all lots tested by sites using JSC and CLS methods
Reference strains Antimicrobial
agents
JSC method CLSI method
Lots tested Lots tested
A B C Ave. A B C Ave.
H. inﬂuenzae ATCC 49247 ABPC 4.7 4.6 4.7 4.7 4.7 4.3 4.5 4.5
ACV 4.2/2.1 4.1/2.0 4.1/2.0 4.1/2.0 4.4/2.2 4.4/2.2 4.4/2.2 4.4/2.2
T/S 0.10/1.97 0.09/1.69 0.10/1.91 0.10/1.85 0.10/1.98 0.10/1.86 0.11/2.13 0.10/1.99
CTRX 0.12 0.11 0.12 0.11 0.12 0.11 0.12 0.11
AZM 0.96 1.01 1.09 1.02 0.73 0.69 0.78 0.73
CPFX 0.023 0.024 0.024 0.024 0.02 0.024 0.023 0.022
H. inﬂuenzae ATCC 49766 MEPM 0.039 0.039 0.039 0.039 0.038 0.037 0.036 0.037
CFDN 0.18 0.17 0.19 0.18 0.16 0.16 0.15 0.16
Geometric mean MICs (lg/ml)
Table 3 Phase II interlaboratory comparison of the JSC and CLSI geometric mean MICs using 40 reference strains
Sites Antimicrobial agents
ABPC ACV CFDN CTRX
JSC CLSI JSC CLSI JSC CLSI JSC CLSI
A 1.037 0.931 1.268/0.634 1.195/0.597 1.44 0.822 0.057 0.054
B 1.078 0.614 1.375/0.688 1.059/0.53 1.35 0.529 0.091 0.066
C 1.704 1.091 2.147/1.074 1.390/0.695 1.704 1 0.073 0.059
D 0.908 0.245 1.748/0.874 0.837/0.418 1.335 0.857 0.092 0.081
E 1.245 1.116 1.826/0.913 1.494/0.747 1.578 1.157 0.066 0.059
F 1.856 0.981 2.038/1.019 1.400/0.700 1.859 1.059 0.134 0.098
t test (p value) 0.0064 0.0056 \0.0001 0.0123
Overall JSC/CLSI mean ratios 1.86 1.45 1.78 1.22
Sites Antimicrobial agents
MEPM AZM T/S CPFX
JSC CLSI JSC CLSI JSC CLSI JSC CLSI
A 0.076 0.067 1.037 0.689 0.154/2.934 0.261/4.951 0.014 0.013
B 0.093 0.046 1.038 0.626 0.114/2.238 0.181/3.443 0.015 0.012
C 0.147 0.085 1.216 0.707 0.158/3.010 0.255/4.840 0.023 0.019
D 0.123 0.064 0.926 0.686 0.105/2.000 0.161/3.055 0.017 0.011
E 0.127 0.088 0.864 0.538 0.103/1.964 0.192/3.651 0.022 0.021
F 0.178 0.094 1.339 0.764 0.154/2.934 0.195/3.703 0.018 0.014
t test (p value) 0.0023 0.0003 0.0004 0.0034
Overall JSC/CLSI mean ratios 1.69 1.6 0.64 1.21
Geometric mean MICs (lg/ml)
J Infect Chemother (2012) 18:134–143 137
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obtained for b-lactams with the JSC method. Statistically
signiﬁcant differences were observed for ABPC and CFDN
(p = 0.0124 and 0.0420, respectively).
The MIC results were also similar for AZM, as the JSC
geometric mean MICs were signiﬁcantly higher than MICs
generated using the CLSI method (p = 0.0025). For T/S,
the mean MICs were again higher with the CLSI method
(p = 0.0030). Although a statistically signiﬁcant difference
was not seen, the CPFX MICs generated by the JSC
method were somewhat higher.
Comparison of growth on media used in the JSC
and CLSI methods
Assessment of growth reported from participating sites
In Table 5, the results of interlaboratory growth assess-
ments for JSC and CLSI media using 40 reference strains
are displayed for the 6 participating sites. When growth
was classiﬁed as either good growth, poor growth observed
in some wells, or poor growth, a geometric mean of 35.83
of the isolates were reported to grow well on JSC media
Table 4 Phase II interlaboratory comparison of the geometric mean MICs generated by JSC and CLSI for consecutive clinical H. inﬂuenzae
isolates (lg/ml)
Sites (no. of isolates) Antimicrobial agents
ABPC ACV CFDN CTRX
JSC CLSI JSC CLSI JSC CLSI JSC CLSI
A (30) 1.466 1.466 1.332/0.666 1.652/0.826 1.182 1.27 0.015 0.015
B (30) 1.823 1.203 1.662/0.831 1.447/0.724 1.32 1.023 0.031 0.024
C (30) 2.895 1.587 2.895/1.447 1.447/0.724 1.866 1.203 0.029 0.021
D (25) 2.173 1.84 1.647/0.824 1.474/0.737 1.474 1.434 0.019 0.018
E (32) 2.52 1.414 1.682/0.841 1.682/0.841 1.231 1.164 0.021 0.018
F (150) 1.741 1.397 1.741/0.871 1.391/0.695 1.598 1.211 0.016 0.015
t test (p value) 0.0124 0.1004 0.042 0.2548
Overall JSC/CLSI mean ratios 1.42 1.43 1.2 1.15
Sites (no. of isolates) Antimicrobial agents
MEPM AZM T/S CPFX
JSC CLSI JSC CLSI JSC CLSI JSC CLSI
A (30) 0.096 0.119 1.074 0.699 0.066/1.246 0.206/3.923 0.015 0.015
B (30) 0.119 0.082 1 0.561 0.072/1.364 0.181/3.437 0.031 0.024
C (30) 0.177 0.119 1.382 0.776 0.030/1.134 0.104/1.974 0.029 0.021
D (25) 0.122 0.1 0.717 0.46 0.042/0.805 0.095/1.780 0.019 0.018
E (32) 0.203 0.107 0.912 0.635 0.119/2.268 0.166/3.147 0.021 0.018
F (150) 0.101 0.099 0.846 0.572 1.029/2.058 1.749/3.499 0.016 0.015
t test (p value) 0.0587 0.0025 0.003 0.153
Overall JSC/CLSI mean ratios 1.31 1.6 0.51 1.16
Geometric mean MICs (lg/ml)
Table 5 Phase II
interlaboratory comparative
visual assessment of growth
obtained using the JSC and
CLSI methods for 40 reference
organisms
Sites Good growth Poor growth in some wells Overall poor growth
JSC CLSI JSC CLSI JSC CLSI
A 38 39 0 0 2 1
B 37 37 0 0 3 3
C 37 28 0 9 3 3
D 35 34 1 2 4 4
E 36 33 12 13 2 4
F 32 20 6 18 2 2
Mean 35.83 31.83 3.17 7 2.67 2.83
t test (p value) 0.1124 0.1626 0.3906
138 J Infect Chemother (2012) 18:134–143
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compared to 31.83 for the CLSI media. Poor growth in
some wells was observed in 3.17 isolates with JSC media
compared to 7.00 isolates on the CLSI media. Poor overall
growth was seen in 2.67 isolates using the JSC media
compared to 2.83 on the CLSI media. While no statistical
difference was observed with visual readings, the overall
assessment was that there was superior growth using the
JSC method.
Comparative assessment of growth using the JSC and CLSI
methods by OD readings The results of an interlabora-
tory growth assessment based on OD readings at 24 and
48 h of incubation for the JSC and CLSI methods using 40
reference strains are displayed for the 6 participating sites
in Table 6. The data were further analyzed by dividing the
40 H. inﬂuenzae isolates up based on the presence of ABPC
resistance genes (BLNAR, low-BLNAR, BLNAS and
BLPAR). After 24 h of incubation, a higher OD was
observed for the JSC method (p\ 0.0001). The difference
was most pronounced at 48 h of incubation (p\ 0.0001).
For BLNAS, there was no signiﬁcant growth difference at
24 h, although superior growth at 48 h was observed with
the JSC method (Table 7a–d).
Discussion
In early 2008, members of the Japanese Chemotherapy
Society working in clinical laboratories or engaged in
research activities as well as members of the Japanese
Society for Clinical Microbiology were sent questionnaires
on reported issues with the microbroth dilution testing of
H. inﬂuenzae. Among the 1,348 surveys sent out, there
were responses from 464 members; 76% of those members
were employed in clinical laboratories, and 2.6% were
employed in research activities. Of those responding, 80%
reported that microbroth dilution testing was used at their
institutions and that 76% of those performing microbroth
dilution testing followed the CLSI procedure. The most
frequent problem reported when testing the antimicrobial
sensitivity of H. inﬂuenzae using the CLSI method was the
difﬁculty involved in interpreting endpoints.
It was previously believed that the addition of animal
blood products to the medium to satisfy the complex
growth requirements of H. inﬂuenzae complicated the
interpretation of antimicrobial susceptibility test results [4].
Complex additives can also contribute to lot-to-lot vari-
ability in media performance. In order to improve the
reliability of H. inﬂuenzae antimicrobial susceptibility
testing, Jorgensen et al. [5] proposed the use of HTM,
which was based on addition of 15 mg/l of hematin,
15 mg/l of NAD and 5 g/l of yeast extract to cation-
adjusted MHB. In 1990, the subcommittee of the NCCLS
recommended the use of HTM as the reference method for
H. inﬂuenzae antimicrobial susceptibility testing. Since the
adoption of HTM as the reference method, a number of
studies have reported on the failure of HTM to support the
growth of all strains of H. inﬂuenzae as well as the inﬂu-
ence of lot-to-lot MHB variability on overall test perfor-
mance, reﬂecting the movement of clinical microbiology
laboratories away from HTM [6]. Based on a survey among
participating clinical microbiology laboratories, it is
believed that HTM is used in 55% of laboratories (Ronald
N. Jones, personal communication). Furthermore, the cur-
rent practice in clinical microbiology laboratories in the
United States is to focus only on b-lactamase-producing
H. inﬂuenzae. In many laboratories, isolates from nonin-
vasive specimens such as sputum are tested only for
b-lactamase production; no antimicrobial susceptibility
testing is performed.
Based on the above, and the need to address differing
clinical microbiological and medical practice in Japan, the
JSC—despite generally following CLSI recommendations
in the past—made the decision to address the issue of poor
growth on HTM by recommending replacing hemin with
2–5% lysed horse blood in the media formulation as the
standard method for the antimicrobial susceptibility testing
of H. inﬂuenzae [2]. With this as a backdrop, the JSC
Subcommittee on Improving Microdilution Antimicrobial
Agent Susceptibility Testing made the decision to compare
the performances of the JSC and CLSI reference methods
for H. inﬂuenzae susceptibility testing.
In phase I of the project, the committee focused on the
lot-to-lot variation that is inherent to supplements of the
medium for the antimicrobial susceptibility testing of
H. inﬂuenzae, using the 2 QC strains recommended by the
CLSI. We found that there was no lot-to-lot variation in the
3 lots when tested by both the CLSI and JSC methods.
The interlaboratory phase II study, which involved the
use of 40 reference strains and consecutive isolates
recovered at each participating site, revealed that b-lactam,
AZM and CPFXMICs generated by the JSC method were
higher, although in some cases differences were not sta-
tistically signiﬁcant.
Barry et al. compared the performance of each method
of microbroth dilution, agar dilution, E-test, and disk dif-
fusion using 8 media including HTM for H. inﬂuenzae
antimicrobial susceptibility testing. Compared to HTM,
media supplemented with either lysed horsed blood with
NAD supplementation, chocolate agar, or Fildes enrich-
ment generated higher MICs or smaller zones of inhibition.
The authors concluded that the inclusion of animal blood
products led to better overall growth of H. inﬂuenzae [6, 7].
With respect to the assessment of growth in phase II
during the determination of MICs, visual readings from
each site reported that superior growth was observed on
J Infect Chemother (2012) 18:134–143 139
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JSC media compared to the CLSI HTM media; however,
this difference did not reach statistical signiﬁcance. During
the interlaboratory phase, when 40 reference strains
representing BLNAS, BLNAR, low BLNAR and BLPAR
were used, OD readings after 24 and 48 h of incubation
revealed that OD readings at 24 h were higher for the JSC
Table 6 Comparison of growth
on the basis of OD readings at
24 and 48 h using the 40
reference organisms
Isolate At 24 h At 48 h
JSC CLSI JSC CLSI
Hi2-1 0.608 0.239 0.787 0.126
Hi2-2 0.816 0.092 1.035 0.025
Hi2-3 0.146 0.089 0.642 0.03
Hi2-4 0.246 0.175 0.58 0.136
Hi2-5 0.343 0.146 0.5 0.075
Hi2-6 0.248 0.135 0.395 0.15
Hi2-7 0.196 0.086 0.297 0.1
Hi2-8 0.024 0.004 0.125 0
Hi2-9 0.802 0.124 1.134 0.044
Hi2-10 0.151 0.109 0.322 0.053
Hi2-11 0.066 0.132 0.412 0.081
Hi2-12 0.491 0.05 0.614 0.011
Hi2-13 0.176 0.101 1.072 0.031
Hi2-14 0.028 0.007 0.114 0
Hi2-15 0.173 0.116 0.878 0.075
Hi2-16 0.782 0.153 1.027 0.122
Hi2-17 0.782 0.128 0.617 0.073
Hi2-18 0.149 0.172 0.474 0.125
Hi2-19 0.264 0.138 1.113 0.086
Hi2-20 0.189 0.139 1.027 0.08
Hi2-21 0.818 0.378 0.707 0.247
Hi2-22 0.182 0.085 1.106 0.044
Hi2-23 0.183 0.13 0.939 0.11
Hi2-24 0.215 0.274 1.055 0.3
Hi2-25 0.127 0.115 0.896 0.081
Hi2-26 0.148 0.105 0.282 0.055
Hi2-27 0.173 0.212 0.35 0.196
Hi2-28 0.179 0.128 1.078 0.061
Hi2-29 0.247 0.19 0.857 0.206
Hi2-30 0.116 0.025 0.163 0.009
Hi2-31 0.146 0.135 0.345 0.096
Hi2-32 0.158 0.199 0.353 0.177
Hi2-33 0.461 0.493 1.068 0.548
Hi2-34 0.178 0.121 0.404 0.107
Hi2-35 0.134 0.165 0.293 0.099
Hi2-36 0.592 0.157 0.733 0.109
Hi2-37 0.482 0.125 0.714 0.08
Hi2-38 0.174 0.22 0.51 0.202
Hi2-39 0.187 0.119 1.005 0.079
Hi2-40 0.242 0.152 0.6 0.114
Mean 0.296 0.147 0.666 0.109
SD 0.234 0.088 0.317 0.096
t test (p value) \0.0001 \0.0001
140 J Infect Chemother (2012) 18:134–143
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Table 7 OD growth
comparison of 40 reference
isolates at 24 and 48 h,
classiﬁed according to the
ampicillin resistance genes
present
Ampicillin resistance Isolate At 24 h At 48 h
JSC CLSI JSC CLSI
(a) BLNAR
Hi2-1 0.608 0.239 0.787 0.126
Hi2-2 0.816 0.092 1.035 0.025
Hi2-7 0.196 0.086 0.297 0.1
Hi2-9 0.802 0.124 1.134 0.044
Hi2-10 0.151 0.109 0.322 0.053
Hi2-11 0.066 0.132 0.412 0.081
Hi2-13 0.176 0.101 1.072 0.031
Hi2-15 0.173 0.116 0.878 0.075
Hi2-16 0.782 0.153 1.027 0.122
Hi2-17 0.782 0.128 0.617 0.073
Hi2-18 0.149 0.172 0.474 0.125
Hi2-19 0.264 0.138 1.113 0.086
Hi2-22 0.182 0.085 1.106 0.044
Hi2-26 0.148 0.105 0.282 0.055
Hi2-30 0.116 0.025 0.163 0.009
Hi2-33 0.461 0.493 1.068 0.548
Hi2-34 0.178 0.121 0.404 0.107
Hi2-35 0.134 0.165 0.293 0.099
Hi2-36 0.592 0.157 0.733 0.109
Hi2-38 0.174 0.22 0.51 0.202
Mean 0.348 0.148 0.686 0.106
SD 0.266 0.092 0.336 0.11
t test (p value) 0.002 \0.0001
(b) Low BLNAR
Hi2-8 0.024 0.004 0.125 0
Hi2-12 0.491 0.05 0.614 0.011
Hi2-14 0.028 0.007 0.114 0
Hi2-20 0.189 0.139 1.027 0.08
Hi2-21 0.818 0.378 0.707 0.247
Hi2-31 0.146 0.135 0.345 0.096
Hi2-39 0.187 0.119 1.005 0.079
Hi2-40 0.242 0.152 0.6 0.114
Mean 0.266 0.123 0.567 0.078
SD 0.249 0.111 0.331 0.077
t test (p value) 0.0332 0.0019
(c) BLNAS
Hi2-3 0.146 0.089 0.642 0.03
Hi2-4 0.246 0.175 0.58 0.136
Hi2-6 0.248 0.135 0.395 0.15
Hi2-23 0.183 0.13 0.939 0.11
Hi2-24 0.215 0.274 1.055 0.3
Hi2-25 0.127 0.115 0.896 0.081
Hi2-27 0.173 0.212 0.35 0.196
Hi2-28 0.179 0.128 1.078 0.061
Hi2-29 0.247 0.19 0.857 0.206
Hi2-32 0.158 0.199 0.353 0.177
Hi2-37 0.482 0.125 0.714 0
Mean 0.219 0.161 0.714 0.139
SD 0.093 0.051 0.26 0.074
t test (p value) 0.0613 \0.0001
(d) BLPAR
Hi2-5 0.343 0.146 0.5 0.075
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medium than the CLSI medium. This difference in tur-
bidity was even greater at 48 h (Tables 6, 7). The failure to
demonstrate a statistically signiﬁcant difference in growth
between the CLSI and JSC media based on visual assess-
ment may be attributed to the fact that MIC readings are
taken at 20–24 h of incubation, when turbidity differences
are not as pronounced. If an OD reading of 0.2 is set as a
cut-off for growth, many readings will fall below this
threshold when using the CLSI medium, whereas less than
one-half of all readings will fall below this threshold when
using the JSC medium. It can thus be deﬁnitively con-
cluded that superior growth is achieved with JSC medium.
The one exception to better growth with JSC media was
observed when testing T/S, in which case the CLSI HTM
medium showed higher MIC values. Although not shown
in Table 2, the geometric mean MIC when ATCC 49766
H. inﬂuenzae was tested on the CLSI medium was 0.19/
3.61 lg/ml, compared to 0.04/0.76 lg/ml with the JSC
medium, which reﬂects a greater than twofold difference in
dilution. Jorgensen et al. reported that MICs for T/S were
lower when using 5% lysed horse blood compared to HTM
[5]. The action of sulfonamides can be antagonized by
peptones and other constituents. This antagonism can occur
even in a non-peptone-containing medium such as MH
medium. The neutralization of antagonism with respect to
sulfonamides through the addition of lysed horse blood has
been reported by the JSC Subcommittee on Trimethoprim-
Sulfamethoxazole MIC Testing [8].
The antimicrobial agents used in Japan and the United
States to treat infections caused by H. inﬂuenzae differ. T/S
is used more often in the United States, while it is rarely
used in Japan. A lower MIC value for T/S is generated by
the JSC method, but the subcommittee feels that this has
minimal clinical implications, as categorical interpretations
do not change.
Among the ampicillin-resistant H. inﬂuenzae isolates
recovered in Japan, BLNAR strains with lower MICs than
b-lactamase-producing strains predominate. In contrast,
BLPAR strains that generate high MICs are frequently
isolated in the United States. If the JSC method is more
effective at detecting BLNAR as it supports its growth
better, this would be a positive contribution, as BLNAR
strains are much more frequently seen in Japan than
BLPAR strains. BLNAR strains exhibit an ampicillin
MIC of about 4 lg/ml. Strains that are conﬁrmed to be
low-BLNAR strains based on molecular testing exhibit an
MIC of B2 lg/ml, which is deﬁned as intermediate
resistance or susceptible according to the CLSI. There-
fore, the use of the JSC method, which generates slightly
higher MIC values than the CLSI method, should result in
increased detection of BLNAR strains and reduce the rate
of failure to detect these strains, which may be clinically
signiﬁcant.
This project reﬂects the third evaluation of the JSC
method for testing the antimicrobial susceptibility of
H. inﬂuenzae. In conclusion, this subcommittee concludes
its activities on the comparison of CLSI and JSC methods
with the annotations (Appendix) shown below.
Appendix
The Japanese Society of Chemotherapy Committee on
Microdilution Susceptibility Testing has studied the prob-
lem of Haemophilus inﬂuenzae microdilution testing. The
ﬁndings of the committee are found as amendments to the
following:
II. Antimicrobial susceptibility testing of fastidious
bacteria (Amendment 1)
Note 1
The CLSI Standard for determination of MICs when testing
Haemophilus inﬂuenzae and H. parainﬂuenzae isolates is
based on the use of Haemophilus Test Medium (HTM)
broth while the Japanese Society of Chemotherapy rec-
ommended method is based on the addition of lysed horse
blood (Table 8).
Based on a survey conducted by JSC, the problems
associated with HTM media in routine use were poor
growth of some strains as well as difﬁculties in endpoint
determinations. In response to the need to better understand
the variables, we initiated an extensive comparative study
of the CLSI and JSC methods for antimicrobial suscepti-
bility of H. inﬂuenzae involving a number of participating
sites throughout Japan. The results of this study showed
that the JSC method media was superior for growth of
BLNAS, BLPAR and BLNAR. Furthermore, the result of
better growth on the JSC method media resulted in MICs
Table 8 A Comparison of the CLSI and JSC recommended media
for MIC determinations when testing H. inﬂuenzae and
H. parainﬂuenzae
CLSI Methoda JSC Method
To CAMHB (1 l), the following
supplements are added:
To CAMHB (1 l), the following
supplements are added:
Hematin 15 mg NAD 15 mg
NAD 15 mg Yeast extract 5 g
Yeast extract 5 g Lysed horse blood 2–5%
a For testing of sulfonamides and trimethoprim, 0.2 IU of thymidine
phosphorylase is added. H. inﬂuenzae ATCC10211 is recommended
for quality control
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being 1.5-fold higher (range 1.15–1.86) for b-lactams and
macrolides. This ﬁnding was previously reported by
Jorgensen et al. [5]. Although the MICs for trimethoprim-
sulfamethoxazole generated by the JSC method tend to be
higher than the CLSI, an analysis of the MICs by the JSC
found that categorical interpretations did not change and
would have minimal clinical implications. Furthermore, the
poorer growth on CLSI method media led to higher false
negative detection of BLNAR, which is more prevalent in
Japan compared to the USA. Based on these ﬁndings, the
JSC concludes that the JSC antimicrobial susceptibility
MIC method for H. inﬂuenzae is superior to the CLSI
method.
Note 2
With respect to trimethoprim-sulfamethoxazole, the JSC
method generates MICs that are 1.5-fold lower as a result
of lysed horse blood neutralizing peptones and other
antagonists found in MH base media (Trimethoprim-
Sulfamethoxazole MIC Testing Subcommittee [8]). As
trimethoprim-sulfamethoxazole is seldom used in Japan
and categorical interpretations are not affected, the higher
MICs generated using the JSC method have minimal
clinical implications.
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